Peter A Bednarski Fund For Brain Tumor Research I - NJ Essex, Roseland 07068

Peter A Bednarski Fund For Brain Tumor Research I entered the industry of Advocacy Group in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 813319, which describes it as a Advocacy Group. For further clarification, the SIC classifies this business under the code 8399 and described it as a Advocacy Group. The business provides service to the BOTH market.

To acquire more information, please contact Betty Bednarski by calling (973) 287-6100 during business hours. You can also write to the business’ Single Location at 100 Schweinberg Drive, Roseland, New Jersey NJ 07068. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Peter A Bednarski Fund For Brain Tumor Research I
Representative: Betty Bednarski
Place of Business: 100 Schweinberg Drive, Roseland, NJ 07068
Contact Number: (973) 287-6100
Type of Service: Advocacy Group
SIC Number: 8399
NAICS Number: 813319
Locality: Single Location
Market Type: B2B & B2C
Began: 2009
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Peter A Bednarski Fund For Brain Tumor Research I is a company operating from Essex, New Jersey providing professional Advocacy Group and relevant BOTH variables. It was founded in 2009 and registered with the SIC code 8399 as Advocacy Group, and with the NAICS code 813319 as Advocacy Group.

With a current employee count of 1 to 4, Peter A Bednarski Fund For Brain Tumor Research I has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Betty Bednarski at (973) 287-6100 for related queries, or to locate its Single Location using the coordinates 40.82434,-74.306988.

The Single Location can also be found at the street address 100 Schweinberg Drive in Roseland, New Jersey 07068 and can be engaged online through the company website at , the company Twitter , and Facebook page .